ALFA Filings
Every announcement, straight from the exchange
Every Sun Pharmaceutical Industries management change announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Sun Pharmaceutical Industries announced the resignation of Independent Director Gautam Doshi due to personal reasons.
Sun Pharmaceutical appointed Dr. Andreas Eugen Busch as an Independent Director for five years. His extensive global R&D expertise will strengthen the board's drug discovery leadership.
Sun Pharmaceutical appointed Dr. Andreas Busch as Independent Director for five years. Ms. Rama Bijapurkar retires, and Ms. Satyavati Berera joins key committees.
Sun Pharmaceutical Industries has appointed Ms. Satyavati Berera as a Non-Executive Independent Director for a five-year term effective May 8, 2026. Ms. Berera, a former COO of PwC India and a Chartered Accountant, brings over 40 years of experience in governance, risk, and operations to the board.
Sun Pharmaceutical Industries has appointed Ms. Satyavati Berera as an Independent Director for a five-year term, subject to shareholder approval. Ms. Berera, a former COO of PwC India, brings extensive expertise in governance, risk, and compliance. This appointment aims to strengthen the Board's independence and oversight capabilities.